063160.KS · 종근당바이오
South Korea · RS rating 37 · As of 2026-10-14
| Price | 13,310.00 KRW |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 65 / 53 / 18 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 19 / 20 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | -166.2% |
| Sales growth Q/Q | +1.0% |
| Distance from 52-week high | +44.1% |
| Market cap (USD) | $57.2M |